In Cancer Research, Diet and Exercise Roles Strengthen

The theory that a healthy diet and regular exercise can be key factors in staving off cancer surfaces again. The latest support comes from researchers spanning from the United Kingdom, across the Atlantic, to the shores of the Pacific Ocean--researchers at the Imperial College of Medicine and the UK's Institute of Food Research studying colon cancer, and investigators at the University of California at Los Angeles looking into prostate cancer. The UCLA researchers found that a low-fat, high-fib

Written byA. J. S. Rayl
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

The UCLA researchers found that a low-fat, high-fiber diet and daily exercise can slow prostate cancer cell growth. "This is the first study to directly measure the effects of diet and exercise on inhibiting growth of prostate cancer cells and it strongly suggests that a low-fat diet and exercise regimen favorably affects the levels of hormones or growth factors that influence prostate cancer growth," says William Aronson, senior author of the study that appeared recently in Journal of Urology.1

Aronson and colleagues at the Jonsson Cancer Center and the department of physiological science studied two groups of healthy men, aged 38 to 74--a short-term group comprised of 13 overweight men who did not have a history of eating healthy or exercising regularly, and a long-term group that featured eight men who had subscribed to healthy living for 14 years or more. They put both groups on a strict 11-day diet ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies